These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33464849)

  • 1.
    Liu F; Yang L; Li Y; Junier A; Ma F; Chen J; Han H; Glass Z; Zhao X; Kumamoto CA; Sang H; Xu Q
    ACS Biomater Sci Eng; 2020 Feb; 6(2):1064-1073. PubMed ID: 33464849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphotericin B formulations: a comparative review of efficacy and toxicity.
    Hamill RJ
    Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
    Alvarez C; Shin DH; Kwon GS
    Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations.
    Fukui H; Koike T; Nakagawa T; Saheki A; Sonoke S; Tomii Y; Seki J
    Int J Pharm; 2003 Nov; 267(1-2):101-12. PubMed ID: 14602388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.
    Radwan MA; AlQuadeib BT; Šiller L; Wright MC; Horrocks B
    Drug Deliv; 2017 Nov; 24(1):40-50. PubMed ID: 28155565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable functional polycarbonate micelles for controlled release of amphotericin B.
    Wang Y; Ke X; Voo ZX; Yap SSL; Yang C; Gao S; Liu S; Venkataraman S; Obuobi SAO; Khara JS; Yang YY; Ee PLR
    Acta Biomater; 2016 Dec; 46():211-220. PubMed ID: 27686042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system.
    Tabosa Do Egito ES; Appel M; Fessi H; Barratt G; Puisieux F; Devissaguet JP
    J Antimicrob Chemother; 1996 Sep; 38(3):485-97. PubMed ID: 8889723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models.
    Usman F; Nopparat J; Javed I; Srichana T
    Drug Deliv Transl Res; 2020 Feb; 10(1):59-69. PubMed ID: 31368043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.
    Zia Q; Khan AA; Swaleha Z; Owais M
    Int J Nanomedicine; 2015; 10():1769-90. PubMed ID: 25784804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
    Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
    J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.
    Tang X; Zhu H; Sun L; Hou W; Cai S; Zhang R; Liu F
    Int J Nanomedicine; 2014; 9():5403-13. PubMed ID: 25473279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating.
    Petit C; Chéron M; Joly V; Rodrigues JM; Bolard J; Gaboriau F
    J Antimicrob Chemother; 1998 Dec; 42(6):779-85. PubMed ID: 10052902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphotericin B loaded ethyl cellulose nanoparticles with magnified oral bioavailability for safe and effective treatment of fungal infection.
    Kaur K; Kumar P; Kush P
    Biomed Pharmacother; 2020 Aug; 128():110297. PubMed ID: 32480227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
    Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
    Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone.
    Italia JL; Yahya MM; Singh D; Ravi Kumar MN
    Pharm Res; 2009 Jun; 26(6):1324-31. PubMed ID: 19214716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole.
    Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga M; Alonso R; del Valle O; Rodriguez V; Arévalo MP; Salgado J; Martin-Mazuelos E; Bornay-Llinares FJ; del Palacio A; Cuétara M; Gasser I; Hernández-Molina JM; Pemán J
    Chemotherapy; 2000; 46(4):235-44. PubMed ID: 10859429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
    Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G
    Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing efficacy of amphotericin B through nanomodification.
    Vyas SP; Gupta S
    Int J Nanomedicine; 2006; 1(4):417-32. PubMed ID: 17722276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.